Carelink Psykiatri ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 8.5% 33.1% 4.7%  
Credit score (0-100)  0 0 27 0 45  
Credit rating  N/A N/A BB C BBB  
Credit limit (kDKK)  0.0 0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 1,942 5,406 8,250  
EBITDA  0.0 0.0 -1,050 -959 -7,562  
EBIT  0.0 0.0 -1,050 -1,081 -7,686  
Pre-tax profit (PTP)  0.0 0.0 -1,111.1 -1,271.3 -7,911.6  
Net earnings  0.0 0.0 -867.0 -996.7 -6,175.9  
Pre-tax profit without non-rec. items  0.0 0.0 -1,111 -1,271 -7,912  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 227 1,946  
Shareholders equity total  0.0 0.0 -827 -324 7,235  
Interest-bearing liabilities  0.0 0.0 1,113 49.8 0.0  
Balance sheet total (assets)  0.0 0.0 742 1,628 10,218  

Net Debt  0.0 0.0 1,113 -106 -978  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 1,942 5,406 8,250  
Gross profit growth  0.0% 0.0% 0.0% 178.4% 52.6%  
Employees  0 0 4 7 20  
Employee growth %  0.0% 0.0% 0.0% 75.0% 185.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 742 1,628 10,218  
Balance sheet change%  0.0% 0.0% 0.0% 119.6% 527.5%  
Added value  0.0 0.0 -1,050.4 -1,080.6 -7,561.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 105 1,595  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% -54.1% -20.0% -93.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -67.0% -61.4% -126.3%  
ROI %  0.0% 0.0% -90.4% -178.3% -211.0%  
ROE %  0.0% 0.0% -116.9% -84.1% -139.4%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% -52.7% -16.6% 70.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -105.9% 11.1% 12.9%  
Gearing %  0.0% 0.0% -134.5% -15.4% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 10.9% 32.8% 907.7%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.4 0.6 2.5  
Current Ratio  0.0 0.0 0.4 0.6 2.5  
Cash and cash equivalent  0.0 0.0 0.0 156.2 977.5  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -935.0 -721.8 4,426.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -263 -154 -378  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -263 -137 -378  
EBIT / employee  0 0 -263 -154 -384  
Net earnings / employee  0 0 -217 -142 -309